Home › Funds › Systrade AG › NTRA
Systrade AG position in NTRA
NATERA INC · Health Care
Systrade AG reported holding 50,000 shares of NTRA (NATERA INC) in its Q3 2026 13F filing — a position valued at US$20.7M, representing 10.47% of its reported portfolio and ranking #5 among its reported holdings. Systrade AG has disclosed NTRA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Systrade AG's NTRA position evolved
Systrade AG first disclosed a stake in NTRA in Q4 2025 at 50,000 shares (US$11.5M). The position peaked in Q3 2026 at 50,000 shares, worth US$20.7M. Across 4 filings, Systrade AG held the position steady without any share-count change. The most recent filing (Q3 2026) shows 50,000 shares valued at US$20.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 50.00K | $11.45M | New |
| Q1 2026 | 50.00K | $10.00M | Hold |
| Q2 2026 | 50.00K | $13.57M | Hold |
| Q3 2026 | 50.00K | $20.67M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NTRA and 13F data
NTRA (NATERA INC) is a Health Care company. 52 other funds we track also report a position in NTRA — the largest reported positions include JPMorgan Chase & Co (US$3.51B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTRA
- JPMorgan Chase & Co 12.87M sh · $3.51B · Q2 2026
- Duquesne Family Office LLC 3.19M sh · $864.92M · Q2 2026
- Castle Hook Partners LP 2.60M sh · $704.76M · Q2 2026
- Coatue Management 2.51M sh · $680.01M · Q2 2026
- COATUE MANAGEMENT LLC 2.51M sh · $680.01M · Q2 2026
- Farallon Capital Management 2.22M sh · $602.18M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.22M sh · $602.18M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.78M sh · $482.64M · Q2 2026
- Sofinnova Investments, Inc. 1.55M sh · $420.82M · Q2 2026
- Maverick Capital 1.36M sh · $368.27M · Q2 2026
- MAVERICK CAPITAL LTD 1.36M sh · $368.27M · Q2 2026
- D. E. Shaw & Co., Inc. 1.28M sh · $347.25M · Q2 2026
More on Systrade AG
FAQ
How long has Systrade AG held NTRA?
Systrade AG has disclosed NTRA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Systrade AG's current position in NTRA?
As of Q3 2026, Systrade AG holds 50.00K shares of NTRA (NATERA INC), valued at $20.67M, representing 10.47% of its reported portfolio and ranking #5.
Has Systrade AG been buying or selling NTRA?
In the latest 13F filing (Q3 2026), Systrade AG held unchanged its position in NTRA. The position peaked in Q3 2026 at 50.00K shares.
Which other funds hold NTRA?
Other major institutional holders of NTRA include JPMorgan Chase & Co, Duquesne Family Office LLC, Castle Hook Partners LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.